People · Operator
Named in public records as an officer, director or promoter · active 2012–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Femasys Inc | — | Biotechnology | Series B | $74.7M | $32.0M | 2012 |
Gary E. Thompson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gary E. Thompson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joshua Silverman | 1 | 8 |
| Charles Larsen | 1 | 7 |
| John Adams | 1 | 6 |
| Parker H. Petit | 1 | 5 |
| Gary Thompson | 1 | 4 |
| Fred Aslan | 1 | 3 |
| John Dyett | 1 | 3 |
| DOV ELEFANT | 1 | 3 |
| Max Azevedo | 1 | 1 |
| Jeffrey A. Marcus | 1 | 1 |
| Daniel S. Currie | 1 | 1 |
| Marcus E. Finch | 1 | 1 |
| Edward R. Uzialko, Jr. | 1 | 1 |
| Lisa Peacock | 1 | 1 |
| Marc Finch | 1 | 1 |
| James Dorsey | 1 | 1 |
| Roberta McCaw | 1 | 1 |
| Lisa E. Peacock | 1 | 1 |
| Marc E. Finch | 1 | 1 |
| Roberta E. McCaw | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.